Single-Cell Phenotypic Profiling of CTCs in Whole Blood Using an Integrated Microfluidic Device
mediaposted on 2019-08-14, 20:06 authored by Haimeng Pei, Lu Li, Yuan Wang, Renjie Sheng, Yiguo Wang, Shuting Xie, Lingling Shui, Haibin Si, Bo Tang
Single-cell phenotypic profiling of circulating tumor cells (CTCs) in the blood of cancer patients can reveal vital tumor biology information. Even though various approaches have been provided to enrich and detect CTCs, it remains challenging for consecutive CTC sorting, enumeration, and single-cell characterizations. Here, we report an integrated microfluidic device (IMD) for single-cell phenotypic profiling of CTCs that enables automated CTCs sorting from whole blood following continuous single-cell phenotypic analysis while satisfying the requirements of both high purity (92 ± 3%) of cell sorting and high-throughput processing capacity (5 mL whole blood/3 h). Using this new technique we test the phenotypes of individual CTCs collected from xenograft tumor-bearing mice and colorectal (CRC) patients at different tumor stages. We obtained a correlation between CTC characterization and clinical tumor stage and treatment response. The developed IMD offers a high-throughput, convenient, and rapid strategy to study individual CTCs toward minimally invasive cancer therapy prediction and disease monitoring and has the potential to be translated to clinic for liquid biopsy.
Read the peer-reviewed publication
tumor stagescancer patientstreatment responsemicrofluidic deviceCTC characterizationcancer therapy predictionphenotypic analysisxenograft tumor-bearing miceIMDWhole Blooddisease monitoringSingle-Cell Phenotypic Profilingtumor cellstumor biology informationCRCtumor stageIntegrated Microfluidic Device